Dealing with adverse events quickly and effectively is crucial to ensuring patient safety.
Global pharmacovigilance compliance requirements – whether from the Food and Drug Administration (FDA), the European Medicines Agency (EMA), or other bodies – are strict and impose very short turnaround times for pharma and medical device companies to file adverse event reports.
Due to its decentralised nature across different locations, the case intake and reporting process is typically highly manual, and resource intensive. Not only that, it can be quite costly, even without penalties for delays and late filings, and that is before we even talk about the multiple languages involved.
It doesn’t have to be this way. The pharmacovigilance process is ripe for innovation, through Robotic Process Automation in the case intake workflow. Critical time savings. Massive cost savings. Zero impact on quality.
Are you ready to future proof your case intake workflow?
Case volumes growing exponentially
Effort and cost intensive
Highly manual process
Traditional methods are slow
Regulatory filing deadlines (fines)
Delays to market equates to lost revenue
Iconic’s bespoke Neural Machine Translation solution for pharmacovigilance integrates directly into the case intake workflow, to more effectively process multilingual information, thereby allowing for the rapid processing of large volumes of foreign language adverse event reports.
Iconic’s automation solution is not just for translation; throughout the case intake workflow there are many processes that can be accelerated with automation. Iconic’s custom built solution dramatically reduces the time it takes to report on adverse events. Plain and simple.
In this video Iconic’s Global Head of Enterprise Sales, Diane O’Reilly, shares some specific examples of natural language processing innovation by the life sciences industry.